Since publication of the first edition of this book, the understanding and treatment of ALS have changed dramatically. The many puzzles of this disease are being steadily solved. One cause of familial ALS has been identified, and the mechanisms of motor neuron cell death are much better understood. The FDA has approved riluzole, the first drug available for the treatment of ALS. Additional drugs are being tested and others are on the horizon. This comprehensive guide covers every aspect of the management of ALS. Beginning with discussions of clinical features of the disease, diagnosis, and an overview of symptom management. Major sections deal with medical and rehabilitative management, living with ALS, managing advanced disease, end-of-life issues, and resources that can provide support and assistance. Regardless of their views about long-range events, everyone dealing with the reality of ALS wants to know what to do now. Issues that they have or will need to deal with include: * whether to participate in therapeutic trials * the role of rehabilitation treatments * the use of riluzole (Rilutek), as well as new experimental preparations and drugs that have been approved for some other disease and are being used in ALS
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
ALS, also known as """"Lou Gehrig's disease"""", cannot be cured but it can be treated. A great deal can be done by physicians and other health care professionals to treat the symptoms of ALS, to improve the patient?s quality of life, and to help caregivers and families to cope with the disease. This extensively revised and rewritten new edition is specifically addressed to the needs of patients and families living with the reality of ALS. Since publication of the first edition of this book, the understanding and treatment of ALS have changed dramatically. The many puzzles of this disease are being steadily solved. One cause of familial ALS has been identified, and the mechanisms of motor neuron cell death are much better understood. The FDA has approved riluzole, the first drug available for the treatment of ALS. Additional drugs are being tested and others are on the horizon. This comprehensive guide covers every aspect of the management of ALS. Beginning with discussions of clinical features of the disease, diagnosis, and an overview of symptom management. Major sections deal with medical and rehabilitative management, living with ALS, managing advanced disease, end-of-life issues, and resources that can provide support and assistance.
Dr. Hiroshi Mitsumoto is the current Medical Director of the ALS Center at Columbia University Medical Center. Previously he was on the faculty of the Cleveland Clinic Foundation where he served as Director of the ALS Center. In 2000 he received the Lou Gehrig Memorial Award from the Muscular Dystrophy Association. He has published widely on the subject.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : ThriftBooks-Dallas, Dallas, TX, Etats-Unis
Paperback. Etat : Good. No Jacket. Former library book; Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less. N° de réf. du vendeur G1888799285I3N10
Quantité disponible : 1 disponible(s)
Vendeur : Better World Books, Mishawaka, IN, Etats-Unis
Etat : Very Good. 2nd. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good. N° de réf. du vendeur 3820496-6
Quantité disponible : 1 disponible(s)
Vendeur : Stillwaters Environmental Ctr of the Great Peninsula Conservancy, Kingston, WA, Etats-Unis
Soft cover. Etat : As New. No Jacket. 2nd Edition. Health. This book is clean, bright, straight and tight with no marks noted. This edition is specifically addressed to the needs of patients and families living with the reality of ALS. Experienced contributors from a wide range of medical and nonmedical fields provide the essential information needed to deal with this disease and many other issues associated with the disease. Proceeds from the sale of this book benefit environmental restoration and education. N° de réf. du vendeur 005423
Quantité disponible : 1 disponible(s)
Vendeur : HPB Inc., Dallas, TX, Etats-Unis
paperback. Etat : Very Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority! N° de réf. du vendeur S_410526852
Quantité disponible : 1 disponible(s)
Vendeur : Southampton Books, Sag Harbor, NY, Etats-Unis
Paperback. Etat : Very Good. 2nd EDITION. Second Edition, Later Printing. Not price-clipped. Published by Demos, 2001. Octavo. Paperback. Book is very good with crease on spine and light shelf/edgewear. 100% positive feedback. 30 day money back guarantee. NEXT DAY SHIPPING! Excellent customer service. Please email with any questions. All books packed carefully and ship with free delivery confirmation/tracking. All books come with free bookmarks. Ships from Sag Harbor, New York. N° de réf. du vendeur 433358
Quantité disponible : 1 disponible(s)
Vendeur : J. HOOD, BOOKSELLERS, ABAA/ILAB, Baldwin City, KS, Etats-Unis
Paperback. 451pp Slight foxing on edges, else very good plus condition with text clean & binding tight. N° de réf. du vendeur 183534
Quantité disponible : 1 disponible(s)
Vendeur : The Calico Cat Bookshop, Ventura, CA, Etats-Unis
Soft Bound. Etat : As New Condition. Second Edition. 451 pages. Size: 8vo - over 7¾" - 9¾. Book. N° de réf. du vendeur 015574
Quantité disponible : 1 disponible(s)
Vendeur : Antiquariat Buchkauz, Herzogenburg, Autriche
8°, Softcover. Etat : Gut. Second Edition. XIII, 451S. good condition Sprache: Englisch Gewicht in Gramm: 765. N° de réf. du vendeur 355108
Quantité disponible : 1 disponible(s)